相似文献
1
Drug discovery for malaria: a very challenging and timely endeavor.
Curr Opin Chem Biol. 2007 Aug;11(4):440-5. doi: 10.1016/j.cbpa.2007.05.038.
2
From hybrid compounds to targeted drug delivery in antimalarial therapy.
Bioorg Med Chem. 2015 Aug 15;23(16):5120-30. doi: 10.1016/j.bmc.2015.04.017. Epub 2015 Apr 11.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
J Med Chem. 2019 Dec 12;62(23):10526-10562. doi: 10.1021/acs.jmedchem.9b00761. Epub 2019 Aug 20.
5
New approaches in antimalarial drug discovery and development: a review.
Mem Inst Oswaldo Cruz. 2012 Nov;107(7):831-45. doi: 10.1590/s0074-02762012000700001.
6
Recent advances in antimalarial drug development.
Med Res Rev. 2007 Jan;27(1):65-107. doi: 10.1002/med.20062.
7
An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
Curr Mol Med. 2020;20(8):583-592. doi: 10.2174/1566524020666200207123253.
8
Comprehensive review on various strategies for antimalarial drug discovery.
Eur J Med Chem. 2017 Jan 5;125:1300-1320. doi: 10.1016/j.ejmech.2016.11.025. Epub 2016 Nov 12.
9
Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439).
J Med Chem. 2017 Apr 13;60(7):2651-2653. doi: 10.1021/acs.jmedchem.7b00299. Epub 2017 Mar 15.
10
A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery.
Eur J Med Chem. 2018 Oct 5;158:917-936. doi: 10.1016/j.ejmech.2018.08.040. Epub 2018 Aug 19.
引用本文的文献
1
Recent Advancement in Drug Development for Treating Malaria using Herbal Medicine and Nanotechnological Approach.
Curr Pharm Des. 2025;31(3):203-218. doi: 10.2174/0113816128321468240828103439.
2
Antimalarial and immunomodulatory potential of chalcone derivatives in experimental model of malaria.
BMC Complement Med Ther. 2022 Dec 12;22(1):330. doi: 10.1186/s12906-022-03777-w.
3
Innovations in Genomics and Big Data Analytics for Personalized Medicine and Health Care: A Review.
Int J Mol Sci. 2022 Apr 22;23(9):4645. doi: 10.3390/ijms23094645.
4
Target-Based Virtual Screening of Natural Compounds Identifies a Potent Antimalarial With Selective Falcipain-2 Inhibitory Activity.
Front Pharmacol. 2022 Apr 6;13:850176. doi: 10.3389/fphar.2022.850176. eCollection 2022.
5
Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria.
Parasite Epidemiol Control. 2022 Feb 16;17:e00244. doi: 10.1016/j.parepi.2022.e00244. eCollection 2022 May.
6
Liposomes for malaria management: the evolution from 1980 to 2020.
Malar J. 2021 Jul 27;20(1):327. doi: 10.1186/s12936-021-03858-0.
7
Targeted repression of apicortin by host microRNA impairs malaria parasite growth and invasion.
Dis Model Mech. 2020 Jun 3;13(6):dmm042820. doi: 10.1242/dmm.042820.
8
Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone-chalcone and isatin-chalcone inhibitors probing the S2 active site pocket.
J Enzyme Inhib Med Chem. 2019 Dec;34(1):547-561. doi: 10.1080/14756366.2018.1564288.
9
Development in Assay Methods for Antimalarial Drug Efficacy Testing: A Systematic Review.
Front Pharmacol. 2017 Oct 23;8:754. doi: 10.3389/fphar.2017.00754. eCollection 2017.
10
Peroxides with Anthelmintic, Antiprotozoal, Fungicidal and Antiviral Bioactivity: Properties, Synthesis and Reactions.
Molecules. 2017 Nov 2;22(11):1881. doi: 10.3390/molecules22111881.
本文引用的文献
1
Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers.
PLoS Clin Trials. 2007 Jan 5;2(1):e6. doi: 10.1371/journal.pctr.0020006.
2
Innovative lead discovery strategies for tropical diseases.
Nat Rev Drug Discov. 2006 Nov;5(11):941-55. doi: 10.1038/nrd2144.
3
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime].
Drug Metab Dispos. 2006 Dec;34(12):1985-94. doi: 10.1124/dmd.106.010587. Epub 2006 Sep 22.
4
Medicines for Malaria Venture: sustaining antimalarial drug development.
Trends Parasitol. 2006 Jul;22(7):301-7. doi: 10.1016/j.pt.2006.05.011. Epub 2006 Jun 6.
5
Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes.
Antimicrob Agents Chemother. 2006 Jun;50(6):2185-91. doi: 10.1128/AAC.00192-06.
6
Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity.
J Med Chem. 2006 May 4;49(9):2731-4. doi: 10.1021/jm058288w.
7
Production of the antimalarial drug precursor artemisinic acid in engineered yeast.
Nature. 2006 Apr 13;440(7086):940-3. doi: 10.1038/nature04640.
8
Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum.
Bioorg Med Chem. 2006 Jan 15;14(2):334-43. doi: 10.1016/j.bmc.2005.08.017. Epub 2005 Oct 10.
9
Public-private partnership: from there to here.
Trans R Soc Trop Med Hyg. 2005 Oct;99 Suppl 1:S9-14. doi: 10.1016/j.trstmh.2005.06.008.
10
Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections.
J Infect Dis. 2005 Jul 15;192(2):319-22. doi: 10.1086/430928. Epub 2005 Jun 7.
Zotero 插件